0001830073-20-000001.txt : 20201102 0001830073-20-000001.hdr.sgml : 20201102 20201102165747 ACCESSION NUMBER: 0001830073-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201102 DATE AS OF CHANGE: 20201102 EFFECTIVENESS DATE: 20201102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HIVE Diversity, Inc. CENTRAL INDEX KEY: 0001830073 IRS NUMBER: 843740986 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-379493 FILM NUMBER: 201281112 BUSINESS ADDRESS: STREET 1: 287 PARK AVENUE SOUTH STREET 2: SUITE 631 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (332) 206-2760 MAIL ADDRESS: STREET 1: 287 PARK AVENUE SOUTH STREET 2: SUITE 631 CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001830073 HIVE Diversity, Inc. 287 PARK AVENUE SOUTH SUITE 631 NEW YORK NY NEW YORK 10010 (332) 206-2760 DELAWARE None None Corporation true 2020 Byron Slosar 287 Park Avenue South Suite 631 New York NY NEW YORK 10010 Executive Officer Director Lisa Rapkin 287 Park Avenue South Suite 631 New York NY NEW YORK 10010 Director Dakotah Eddy 287 Park Avenue South Suite 631 New York NY NEW YORK 10010 Executive Officer Ann Tenenbaum 287 Park Avenue South Suite 631 New York NY NEW YORK 10010 Director Other Technology Decline to Disclose 06b false 2020-10-21 false true true Sale of Series Seed Preferred Stock and Conversion of SAFE Instruments. false 1 2874962 2874962 0 Conversion of $874,983.66 in SAFE Instruments into Series Seed Preferred Stock and cash purchase of $1,999,978 in Series Seed Preferred Stock. false 23 0 0 0 false HIVE Diversity, Inc. Byron Slosar Byron Slosar CEO 2020-11-02